Defects in processing and trafficking of cystic fibrosis transmembrane conductance regulator

被引:0
|
作者
Kunzelmann, K [1 ]
Nitschke, R
机构
[1] Univ Queensland, Dept Physiol & Pharmacol, Brisbane, Qld 4072, Australia
[2] Univ Freiburg, Inst Physiol, D-7800 Freiburg, Germany
来源
EXPERIMENTAL NEPHROLOGY | 2000年 / 8卷 / 06期
关键词
cystic fibrosis transmembrane conductance regulator; CFTR; processing; traffic; cystic fibrosis;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In most epithelial tissues C1(-) transport relies on the cystic fibrosis transmembrane conductance regulator (CFTR) which has dual function as a C1(-) channel and as a regulator of other ion channels. More than 900 different mutations in the CFTR gene are the cause for defective transport of C1(-) and Na+ and impaired secretion or absorption of electrolytes in cystic fibrosis, However, the CFTR mutation Delta F508 is the most common reason for the frequently inherited disease among the Caucasian population. Maturation and processing of Delta F508-CFTR is defective which leads to expression of only very little but functional CFTR in the cell membrane. Understanding the processing and trafficking of CFTR may give a clue to the question as to how the expression and residual function of Delta F508-CFTR can be enhanced, and may lead to the development of new pharmacological tools for the treatment of cystic fibrosis. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:332 / 342
页数:11
相关论文
共 50 条
  • [21] Structure and function of the cystic fibrosis transmembrane conductance regulator
    Morales, MM
    Capella, MAM
    Lopes, AG
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1999, 32 (08) : 1021 - 1028
  • [22] The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis
    Sergeev, Valentine
    Chou, Frank Y.
    Lam, Grace Y.
    Hamilton, Christopher Michael
    Wilcox, Pearce G.
    Quon, Bradley S.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020, 17 (02) : 147 - 154
  • [23] THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE
    TSUI, LC
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (03) : S47 - S53
  • [24] PHOSPHORYLATION OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
    PICCIOTTO, MR
    COHN, JA
    BERTUZZI, G
    GREENGARD, P
    NAIRN, AC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (18) : 12742 - 12752
  • [25] Cystic fibrosis transmembrane conductance regulator and adenosine triphosphate
    Abraham, EH
    Okunieff, P
    Scala, S
    Vos, P
    Oosterveld, MJS
    Chen, AY
    Shrivastav, B
    Guidotti, G
    SCIENCE, 1997, 275 (5304) : 1324 - 1325
  • [26] Pharmacology of CFTR (cystic fibrosis transmembrane conductance regulator)
    Cuthbert, A. W.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 22 - 22
  • [27] A transistor model for the cystic fibrosis transmembrane conductance regulator
    Hunt, William D.
    Mccarty, Nael A.
    Marin, Eduardo Martinez
    Westafer, Ryan S.
    Yamin, Phillip R.
    Cui, Guiying
    Eckford, Andrew W.
    Denison, Douglas R.
    BIOPHYSICAL REPORTS, 2023, 3 (02):
  • [28] ATPase activity of the cystic fibrosis transmembrane conductance regulator
    Li, CH
    Ramjeesingh, M
    Wang, W
    Garami, E
    Hewryk, M
    Lee, D
    Rommens, JM
    Galley, K
    Bear, CE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (45) : 28463 - 28468
  • [29] Misfolding of the cystic fibrosis transmembrane conductance regulator and disease
    Cheung, Joanne C.
    Deber, Charles M.
    BIOCHEMISTRY, 2008, 47 (06) : 1465 - 1473
  • [30] Targeted Activation of Cystic Fibrosis Transmembrane Conductance Regulator
    Villamizar, Olga
    Waters, Shafagh A.
    Scott, Tristan
    Saayman, Sheena
    Grepo, Nicole
    Urak, Ryan
    Davis, Alicia
    Jaffe, Adam
    Morris, Kevin V.
    MOLECULAR THERAPY, 2019, 27 (10) : 1737 - 1748